FDA Inspection
Nordmark Arzneimittel GMBH & Co. KGNordmark Arzneimittel GMBH & Co. KG – FDA Inspection, Feb 17, 2017
Record Details
This FDA Inspection record concerns Nordmark Arzneimittel GMBH & Co. KG, with an inspection on February 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 19e24e38-6d17-4f42-b4ba-8519cb457d81
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006686
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nordmark Arzneimittel GMBH & Co. KG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2025 | Not classified | Office of Inspections and Investigations | |
| August 31, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 29, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nordmark Arzneimittel GMBH & Co. KG
- FDA Inspection 1263912 - 2025-02-13
- FDA Inspection 1241654 - 2023-08-31
- FDA Inspection 1099709 - 2019-08-16
- FDA Inspection 907095 - 2014-11-20
- FDA Inspection 810090 - 2012-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.